Drug Eluting Stent 2024: Vendor Detail, Technologies, Regions, Applications, Mar
Posted by NickyArora on March 31st, 2020
The global drug eluting stent market is anticipated to reach USD 9.2 billion by 2024, according to a new report by Grand View Research, Inc. The increasing geriatric population and the high prevalence of artery diseases are the major factors driving the market growth. Sedentary lifestyles, unhealthy dietary habits, and lack of exercise are some of the factors resulting in the increased prevalence of atherosclerosis. As a result, the demand for Drug Eluting Stents (DES) is escalating as atherosclerosis is widely treated using DES. In addition, a constant decline in the price coupled with the reimbursement coverage is spurring the adoption of DES in the treatment of arterial diseases.
Risks, such as thrombosis and disruption of regrowth of endothelial tissues associated with DES, are challenging the market growth. In addition, stringent regulatory approval guidelines are impeding the market growth by restricting the entry of advanced DES, such as bioabsorbable products, in the developed countries.
Presently, the DES market is highly fragmented with the presence of many players competing with each other. The key players in the market are implementing mergers and acquisitions strategies to strengthen their position in the market by the expansion of market share and customer base.
Further key findings from the study suggest:
In addition, the reimbursement coverage, the presence of a large target patient population, and a well-defined regulatory framework are a few factors that are positively affecting the market.Also See: Drug Eluting, Eluting Stent, Polymer Based, Market Growth, Market, Eluting, Drug
Quality Office Furniture USA Shipped Direct - Madison Liquidators
Nationwide vendor of quality office furnishings including Desks, Office Chairs, Conference Tables, Cubicles and more!